[1]
Aslonov I.F., “IMPACT OF COMORBID CONDITIONS ON THE DEVELOPMENT OF NEPHROTOXICITY IN PATIENTS RECEIVING ANTI-TUBERCULOSIS THERAPY”, CAJM, vol. 1, no. 11, pp. 240–245, Jan. 2026, Accessed: Nov. 18, 2026. Available: https://journals.tnmu.uz/index.php/cajm/article/view/3413